Related Experiment Video
Updated: Jul 9, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Clinical controls and model calibration as keys to complete blood count-based studies of pediatric fistula-in-ano
Shi-Yan Zhang1, Jin-Bao Shi2,3
1Department of Clinical Laboratory, Fuding Hospital, Fujian University of Traditional Chinese Medicine, Fuding 355200, Fujian Province, China.
Insights
This commentary suggests improving the evaluation of complete blood count (CBC) markers for pediatric fistula-in-ano. Enhancements include using clinical controls and rigorous validation for reliable, actionable evidence.
Area of Science:
- Pediatric Surgery
- Hematology
- Diagnostic Accuracy
Background:
- Complete blood count (CBC) markers are explored for diagnosing pediatric fistula-in-ano.
- A single-center study focused on low-cost CBC tests for clinical utility and discrimination.
Abstract:
This commentary appraises a single-center evaluation of complete blood count (CBC) markers for pediatric fistula-in-ano. We commend the pragmatic focus of this study on low-cost tests and the dual assessment of discrimination and clinical utility. To strengthen robustness and generalizability, two priorities are emphasized: First, the use of clinical controls, children with perianal symptoms but without pediatric fistula-in-ano, to avoid spectrum bias; and second rigorous calibration and validation (k-fold or temporal splits, bootstrap optimism correction, calibration intercept/slope, and Brier score), with decision curve analyses derived from validated predictions. Given rapid hematologic maturation, age should be modeled nonlinearly and CBC values should be expressed as age-specific z-scores/percentiles. Additional refinements include clear timing/indication of blood draws, appropriate correlations (Spearman or age-adjusted partials), and odds ratios per interquartile range with multicollinearity checks (variance inflation factor). These steps can translate promising CBC signals into reliable, clinically actionable evidence.
More Related Videos
14:45Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018